Development of antibodies for detection of ERCC1 overexpression, a possible biomarker for cisplatin resistance of cancer

被引：0
|
作者：
Oishi, Takayuki [1 ]
Sasaki, Yuka [1 ]
Fujimori, Hiroaki [1 ]
Shibata, Noriko
Iwasa, Satoru
Nakao, Kazuhiko
Yamada, Yasuhide
Hiraoka, Nobuyoshi
Masutani, Mitsuko [1 ]
机构：
[1] Nagasaki Univ, Grad Sch, Dept Frontier Life Sci, Nagasaki, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
ERCC1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3371
引用
收藏
页码：1148 / 1148
页数：1
相关论文
共 50 条
  • [1] Establishment of monoclonal antibody to detect ERCC1 overexpression, a possible biomarker for cisplatin resistance
    Oishi, Takayuki
    Sasaki, Yuka
    Furusato, Bungo
    Iwasa, Satoru
    Nakao, Kazuhiko
    Yamada, Yasuhide
    Hiraoka, Nobuyoshi
    Masutani, Mitsuko
    CANCER SCIENCE, 2018, 109 : 603 - 603
  • [2] Characterization of monoclonal antibody recognizing ERCC1 overexpression, a potential biomarker for cisplatin response
    Oishi, Takayuki
    Sasaki, Yuka
    Tong, Ying
    Chen Lichao
    Onodera, Takae
    Iwasa, Satoru
    Udo, Emiko
    Furusato, Bungo
    Nakao, Kazuhiko
    Yamada, Yasuhide
    Hiraoka, Nobuyoshi
    Masutani, Mitsuko
    CANCER SCIENCE, 2021, 112 : 915 - 915
  • [3] HIGH LEVELS OF ERCC1 ARE ASSOCIATED WITH CISPLATIN RESISTANCE IN NEUROBLASTOMA
    Meret, Henry
    Wang, Zhihong
    Liu, Yimin
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 784 - 784
  • [4] Participation of ERCC1 in resistance against cisplatin for human esophageal cancer cell lines
    Miyahara, T
    Yanagihashi, K
    Kajiwara, T
    Akaboshi, M
    Kawabe, A
    Kaganoi, JI
    PROCEEDINGS OF THE 37TH CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, 2002, : 195 - 199
  • [5] ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells
    Huang, Yi-Jung
    Huang, Ming-Yii
    Cheng, Tian-Lu
    Kuo, Shih-Hsun
    Ke, Chien-Chih
    Chen, Yi-Ting
    Hsieh, Yuan-Chin
    Wang, Jaw-Yuan
    Cheng, Chiu-Min
    Chuang, Chih-Hung
    CANCERS, 2022, 14 (19)
  • [6] Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas
    Chen, Hua-Yun
    Shao, Cui-Jie
    Chen, Fu-Rong
    Kwan, Aij-Lie
    Chen, Zhong-Ping
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (08) : 1944 - 1954
  • [7] ROLE OF ERCC1 PROMOTER HYPERMETHYLATION IN DRUG RESISTANCE TO CISPLATIN IN HUMAN GLIOMAS
    Chen, H.
    Kwan, A.
    Chen, Z.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1147 - 1147
  • [8] ERCC1 and lung cancer
    Planchard, D.
    Olaussen, K. -A.
    Soria, J. -C.
    REVUE DES MALADIES RESPIRATOIRES, 2010, 27 (04) : 387 - 394
  • [9] Response to GEMOX plus erlotinib in pancreatic cancer is associated with ERCC1 overexpression
    Fuereder, Thorsten
    Stift, Judith
    Kuehrer, Irene
    Stranzl, Nadja
    Hoeflmaye, Doris
    Kornek, Gabriela
    Scheithauer, Werner
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (10) : 958 - 964
  • [10] The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells
    Sun, Yehong
    Li, Tiyuan
    Ma, Kewei
    Tian, Zhongkai
    Zhu, Ying
    Chen, Fuqiang
    Hu, Gang
    CANCER INVESTIGATION, 2009, 27 (09) : 891 - 897
12345